{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:14:06Z","timestamp":1787501646979,"version":"build-2736575974"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/10847-9"],"award-info":[{"award-number":["2016\/10847-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019183","name":"Funda\u00e7\u00e3o da Faculdade de Ci\u00eancias da Universidade de Lisboa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019183","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejmech.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T17:45:30Z","timestamp":1542044730000},"page":"378-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria"],"prefix":"10.1016","volume":"162","author":[{"given":"Cau\u00ea Benito","family":"Scarim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Hartmann","family":"Jornada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella Gabrielle Mendes","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Maria Riberio","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Leandro","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Chin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.11.013_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jhet.1513","article-title":"Synthesis and antimicrobial activity of novel thiazole substituted pyrazole derivatives","volume":"50","author":"Gaikwad","year":"2013","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1590\/S0074-02762013000300013","article-title":"The antimicrobial activity of lapachol and its thiosemicarbazone and semicarbazone derivatives","volume":"108","author":"Souza","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2018.11.013_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bmc.2014.11.029","article-title":"Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF V600E inhibitors","volume":"23","author":"Zhao","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ejmech.2009.11.008","article-title":"Synthesis, anti-bacterial and anti-fungal activities of some novel Schiff bases containing 2,4-disubstituted thiazole ring","volume":"45","author":"Bharti","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.25004\/IJPSDR.2009.010302","article-title":"Thiazoles\u202f: a valuable insight into the recent advances and biological Thiazoles\u202f: a valuable insight into the recent advances and biological activities","volume":"1","author":"Siddiqui","year":"2009","journal-title":"Int. J. Pharmaceut. Sci. Drug Res."},{"key":"10.1016\/j.ejmech.2018.11.013_bib6","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.ejmech.2007.11.012","article-title":"Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives","volume":"43","author":"de Oliveira","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0223-5234(91)90148-G","article-title":"Evaluation of the thiosemicarbazones of some aryl alkyl ketones and related compounds for anticonvulsant activities","volume":"26","author":"Dimmockl","year":"1991","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00044-016-1529-7","article-title":"Broad-spectrum antiproliferative activity of a series of 6-(4-fluorophenyl)-5-(2-substituted pyrimidin-4-yl)imidazo[2,1-b]thiazole derivatives","volume":"25","author":"Abdel-maksoud","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.11.013_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejmech.2015.11.002","article-title":"Synthesis and evaluation of bis-thiazole derivatives as new anticancer agents","volume":"107","author":"Turan-Zitouni","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/1574892810666150708110432","article-title":"Recent patents on thiazole derivatives endowed with antitumor activity","volume":"10","author":"Morigi","year":"2015","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.ejmech.2018.11.013_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/17415990500322792","article-title":"Synthesis and biological activity of natural thiazoles\u202f: an important class of heterocyclic compounds","volume":"26","author":"de Souza","year":"2006","journal-title":"J.\u00a0Sulfur Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejmech.2013.06.029","article-title":"Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1,3,4-oxadiazoles","volume":"67","author":"Desai","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/ijms15011237","article-title":"Synthesis and antimicrobial evaluation of some novel thiazole, pyridone, pyrazole, chromene, hydrazone derivatives bearing a biologically active sulfonamide moiety","volume":"15","author":"Darwish","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2018.11.013_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejmech.2017.12.038","article-title":"Design, synthesis and biological evaluations of novel pyridonethiazole hybrid molecules as antitumor agents","volume":"145","author":"Xie","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bmc.2014.11.029","article-title":"Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAFV600E inhibitors","volume":"23","author":"Zhao","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib16","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates, Geneva World Heal","volume":"90","author":"World and Health Organization (WHO)","year":"2015","journal-title":"Organ"},{"key":"10.1016\/j.ejmech.2018.11.013_bib17","author":"Drugs for Neglected Diseases initiative (DNDi)"},{"key":"10.1016\/j.ejmech.2018.11.013_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1590\/S0074-02761999000700075","article-title":"Epidemiology and dinamics of the vectorial transmission of chagas disease","volume":"94","author":"Sherlock","year":"1999","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2018.11.013_bib19","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2018.11.013_bib20","author":"World and Health Organization (WHO)"},{"key":"10.1016\/j.ejmech.2018.11.013_bib21","series-title":"Trypanosoma cruzi e Doen\u00e7a Chagas","first-page":"88","article-title":"O\u00a0parasita e sua intera\u00e7\u00e3o com os hospedeiros","author":"De Souza","year":"1999"},{"key":"10.1016\/j.ejmech.2018.11.013_bib22","series-title":"Cad. Sa\u00fade P\u00fablica","first-page":"486","article-title":"Cl\u00ednica e terap\u00eautica da doen\u00e7a de Chagas, uma abordagem pr\u00e1tica para o cl\u00ednico geral","author":"Dias","year":"1997"},{"key":"10.1016\/j.ejmech.2018.11.013_bib23","series-title":"Trypanos. Cruzi e Doen\u00e7a Chagas","first-page":"379","article-title":"Patologia da Doen\u00e7a de Chagas","author":"Andrade","year":"2000"},{"key":"10.1016\/j.ejmech.2018.11.013_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4067\/S0716-10182012000100013","article-title":"Eficacia de nifurtimox para el tratamiento de pacientes con enfermedad de Chagas cr\u00f3nica","volume":"29","author":"Fuentes","year":"2012","journal-title":"Rev. Chil. Infectolog\u00eda."},{"key":"10.1016\/j.ejmech.2018.11.013_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4067\/S0716-97602010000300009","article-title":"Chagas disease: Present status of pathogenic mechanisms and chemotherapy","volume":"43","author":"Maya","year":"2010","journal-title":"Biol. Res."},{"key":"10.1016\/j.ejmech.2018.11.013_bib26","first-page":"109","article-title":"Control of Chagas disease: second report of the WHO expert committee (2000\u202f: Brasilia, Brazil)","volume":"905","author":"World Health Organization (WHO)","year":"2002","journal-title":"Organ"},{"key":"10.1016\/j.ejmech.2018.11.013_bib27","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/jm4000616","article-title":"Cloning, characterization, and sulfonamide and thiol inhibition studies of an a-carbonic anhydrase from Trypanosoma cruzi, the causative agent of chagas disease","volume":"56","author":"Pan","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib28","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(96)04128-1","article-title":"Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection","volume":"348","author":"de Andrade","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2018.11.013_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4269\/ajtmh.1998.59.526","article-title":"Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease","volume":"59","author":"Sosa-Estani","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2018.11.013_bib30","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1128\/AAC.02842-14","article-title":"A\u00a0clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole","volume":"58","author":"Da Silva","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.11.013_bib31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic chagas' cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.11.013_bib32","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1128\/AAC.05018-14","article-title":"Population pharmacokinetics of benznidazole in adult patients with Chagas disease","volume":"59","author":"Soy","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.11.013_bib33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1590\/0074-02760150401","article-title":"Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole","volume":"111","author":"Fernandez","year":"2016","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2018.11.013_bib34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1590\/0037-8682-1646-2013","article-title":"Clinical and serological evolution in chronic Chagas disease patients in a 4-year pharmacotherapy follow-up: a preliminary study","volume":"46","author":"Andrade","year":"2013","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"2006","key":"10.1016\/j.ejmech.2018.11.013_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat chagas' disease (american trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib36","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1016\/j.bmc.2015.10.048","article-title":"Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi","volume":"23","author":"De Oliveira Filho","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejmech.2017.09.047","article-title":"Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi","volume":"141","author":"De Oliveira Filho","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2017.02.026","article-title":"Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death","volume":"130","author":"da Silva","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejmech.2016.05.050","article-title":"New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi","volume":"121","author":"Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejmech.2016.01.010","article-title":"Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi","volume":"111","author":"Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib41","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1021\/jm500018m","article-title":"Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in\u00a0vivo activity","volume":"57","author":"\u00c1lvarez","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib42","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1128\/AAC.03814-14","article-title":"Identification of a new amide-containing thiazole as a drug candidate for treatment of chagas' disease","volume":"59","author":"\u00c1lvarez","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.11.013_bib43","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/1087057115569155","article-title":"Repurposing of the open access malaria Box for kinetoplastid diseases identifies novel active scaffolds against trypanosomatids","volume":"20","author":"Kaiser","year":"2015","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2018.11.013_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2014.08.012","article-title":"2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation","volume":"86","author":"Cardoso","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cmdc.201300354","article-title":"Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity","volume":"9","author":"Moreira","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.11.013_bib46","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.bmcl.2017.03.069","article-title":"6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases","volume":"27","author":"Thompson","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.013_bib47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejmech.2014.02.001","article-title":"Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death","volume":"75","author":"Moreira","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejmech.2013.04.022","article-title":"Design, synthesis and biological evaluation of new aryl thiosemicarbazone as antichagasic candidates","volume":"67","author":"Blau","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib49","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1017\/S0031182015000141","article-title":"4-Nitrobenzaldehyde thiosemicarbazone: a new compound derived from S-(-)-limonene that induces mitochondrial alterations in epimastigotes and trypomastigotes of Trypanosoma cruzi","volume":"142","author":"Britta","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2018.11.013_bib50","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/07391102.2016.1176603","article-title":"Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study","volume":"35","author":"Vital","year":"2016","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2018.11.013_bib51","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bmc.2016.02.027","article-title":"Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruzi","volume":"24","author":"Costa","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12011-013-9653-4","article-title":"Potential mechanism of the anti-trypanosomal activity of organoruthenium complexes with bioactive thiosemicarbazones","volume":"153","author":"Demoro","year":"2013","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ejmech.2018.11.013_bib53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jinorgbio.2017.01.011","article-title":"Rhenium(I) tricarbonyl compounds of bioactive thiosemicarbazones: synthesis, characterization and activity against Trypanosoma cruzi","volume":"170","author":"Arce","year":"2017","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jinorgbio.2015.06.018","article-title":"Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites","volume":"153","author":"Fern\u00e1ndez","year":"2015","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-065X.2008.00675.x","article-title":"T\u00a0cells and immunopathogenesis of experimental African trypanosomiasis","volume":"225","author":"Tabel","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejmech.2018.11.013_bib56","author":"World and Health Organization (WHO)"},{"key":"10.1016\/j.ejmech.2018.11.013_bib57","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"Barrett","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2018.11.013_bib58","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-3156.2009.02271.x","article-title":"Trypanosoma brucei gambiense in domestic livestock of kogo and mbini foci (Equatorial Guinea)","volume":"14","author":"Cordon-Obras","year":"2009","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ejmech.2018.11.013_bib59","first-page":"113","article-title":"Epidemiological studies on the animal reservoir of Gambiense sleeping sickness. Part III. Characterization of trypanozoon stocks by isoenzymes and sensitivity to human serum","volume":"33","author":"Mehlitz","year":"1982","journal-title":"Tropenmed. Parasitol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib60","series-title":"SERBIULA (Sistema Libr. 2.0)","first-page":"644","article-title":"The trypanosomes of mammals\u202f: a zoological monograph","author":"Hoare","year":"1972"},{"key":"10.1016\/j.ejmech.2018.11.013_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001896","article-title":"Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign","volume":"6","author":"Sykes","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2018.11.013_bib62","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1021\/jm401178t","article-title":"Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis","volume":"57","author":"Tatipaka","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3923\/jp.2011.31.42","article-title":"Presence of trypanosome species and determination of anaemia in trade cattle at sokoto abattoir, Nigeria","volume":"6","author":"Fajinmi","year":"2011","journal-title":"Res. J. Parasitol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib64","first-page":"313","article-title":"L\u2019\u00e9pid\u00e9miologie de la trypanosomiase humaine africaine\u202f: une histoire multifactorielle complexe","volume":"61","author":"Cattand","year":"2001","journal-title":"Med. Trop."},{"key":"10.1016\/j.ejmech.2018.11.013_bib65","series-title":"A\u00a0Field Guide for the Diagnosis, Treatment and Prevention of African Animal Trypanosomosis","author":"Uilenberg","year":"1998"},{"key":"10.1016\/j.ejmech.2018.11.013_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-4017(00)00427-1","article-title":"Drug resistance in pathogenic African trypanosomes: what hopes for the future?","volume":"96","author":"Anene","year":"2001","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib67","first-page":"157","article-title":"Efficacy of Samorecide-plus in the treatment of experimental Trypanosoma brucei brucei infection of albino rats","volume":"10","author":"Ezeokonkwo","year":"2010","journal-title":"Nig. J Exp Appl. Biol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0001-706X(93)90091-O","article-title":"Pharmacology of existing drugs for animal trypanosomiasis","volume":"54","author":"Kinabo","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2018.11.013_bib69","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1017\/S1462399409001252","article-title":"Trypanocidal drugs: mechanisms, resistance and new targets","volume":"11","author":"Wilkinson","year":"2009","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.ejmech.2018.11.013_bib70","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat chagas' disease (american trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib71","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/cr500365f","article-title":"Recent developments in drug discovery for leishmaniasis and human african trypanosomiasis","volume":"114","author":"Nagle","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.11.013_bib72","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.bmc.2016.04.006","article-title":"Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense","volume":"24","author":"Patrick","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib73","doi-asserted-by":"crossref","first-page":"27456","DOI":"10.1074\/jbc.M113.495101","article-title":"Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei","volume":"288","author":"Lu","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib74","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2016.04.010","article-title":"Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds","volume":"117","author":"Papadopoulou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib75","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1128\/AAC.02006-15","article-title":"Evaluating 5-nitrothiazoles as trypanocidal agents","volume":"60","author":"O'Shea","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.11.013_bib76","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ejmech.2016.12.002","article-title":"In\u00a0vitro activity and mode of action of distamycin analogues against African trypanosomes","volume":"126","author":"Franco","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib77","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/acs.jmedchem.6b01163","article-title":"Urea derivatives of 2-Aryl-benzothiazol-5-amines: a new class of potential drugs for human african trypanosomiasis","volume":"60","author":"Patrick","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib78","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s11033-013-3008-2","article-title":"Trypanocidal and cytotoxic evaluation of synthesized thiosemicarbazones as potential drug leads against sleeping sickness","volume":"41","author":"Glinma","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejmech.2018.11.013_bib79","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.dib.2016.11.044","article-title":"Structural and antitrypanosomal data of different carbasones of piperitone","volume":"9","author":"Sakirigui","year":"2016","journal-title":"Data in Brief"},{"key":"10.1016\/j.ejmech.2018.11.013_bib80","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jinf.2014.07.016","article-title":"Leishmaniasis","volume":"69","author":"Pace","year":"2014","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.ejmech.2018.11.013_bib81","unstructured":"World and Health Organization (WHO), Leishmaniasis, http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis (accessed August 22, 2018)."},{"key":"10.1016\/j.ejmech.2018.11.013_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1590\/S0036-46652006000300007","article-title":"Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control","volume":"48","author":"Dantas-Torres","year":"2006","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.ejmech.2018.11.013_bib83","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/1806-9282.64.03.281","article-title":"Human leishmaniasis in Brazil: a general review","volume":"64","author":"Anversa","year":"2018","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.ejmech.2018.11.013_bib84","doi-asserted-by":"crossref","unstructured":"M. Ghorbani, R. Farhoudi. Leishmaniasis in humans: drug or vaccine therapy?, Drug Des. Dev. Ther. 12 (218) 25\u201340. doi:10.2147\/DDDT.S146521.","DOI":"10.2147\/DDDT.S146521"},{"key":"10.1016\/j.ejmech.2018.11.013_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.05.005","article-title":"In\u00a0vitro evaluation of cytotoxicity and leishmanicidal activity of phthalimido-thiazole derivatives","volume":"105","author":"Alian\u00e7a","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2018.11.013_bib86","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejmech.2015.08.013","article-title":"Aminothiazoles: hit to lead development to identify antileishmanial agents","volume":"102","author":"Bhuniya","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib87","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.bmc.2014.01.029","article-title":"2-Acylamino-5-nitro-1,3-thiazoles: preparation and in\u00a0vitro bioevaluation against four neglected protozoan parasites","volume":"22","author":"Nava-Zuazo","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exppara.2017.04.003","article-title":"Aryl thiosemicarbazones: in\u00a0vitro and immunomodulatory activities against L.\u00a0amazonensis","volume":"177","author":"da Silva","year":"2017","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib89","first-page":"11","article-title":"Hydrazone derivatives enhance antileishmanial activity of thiochroman-4-ones","volume":"23","author":"Vargas","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.11.013_bib90","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejmech.2018.04.003","article-title":"Anti-leishmanial click modifiable thiosemicarbazones: design, synthesis, biological evaluation and in silico studies","volume":"151","author":"Temraz","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041440","article-title":"Benzaldehyde Thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis","volume":"7","author":"Britta","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2018.11.013_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-014-0236-0","article-title":"Cell death and ultrastructural alterations in Leishmania amazonensis caused by new compound 4-Nitrobenzaldehyde thiosemicarbazone derived from S-limonene","volume":"14","author":"Britta","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib93","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.msec.2016.08.021","article-title":"Generating nanoparticles containing a new 4-nitrobenzaldehyde thiosemicarbazone compound with antileishmanial activity","volume":"69","author":"Britta","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejmech.2018.11.013_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.00255","article-title":"Induction of early autophagic process on Leishmania amazonensis by synergistic effect of miltefosine and innovative semi-synthetic thiosemicarbazone","volume":"8","author":"Scariot","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib95","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2016.07.014","article-title":"Arylthiosemicarbazones as antileishmanial agents","volume":"123","author":"Manzano","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib96","series-title":"Guidelines for the Treatment of Malaria","first-page":"3","author":"World Health Organization (WHO)","year":"2015"},{"issue":"4","key":"10.1016\/j.ejmech.2018.11.013_bib97","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00430-012-0272-z","article-title":"Malaria and human red blood cells","volume":"201","author":"Mohandas","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib98","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.ejmech.2018.11.013_bib99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jinorgbio.2013.08.007","article-title":"Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool","volume":"129","author":"Walcourt","year":"2013","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib100","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1039\/c3dt32740j","article-title":"The synthesis and antiparasitic activity of aryl- and ferrocenyl-derived thiosemicarbazone ruthenium(ii)\u2013arene complexes","volume":"42","author":"Adams","year":"2013","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2018.11.013_bib101","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1039\/C5DT04918K","article-title":"Cyclopalladated organosilane\u2013tethered thiosemicarbazones: novel strategies for improving antiplasmodial activity","volume":"45","author":"Adams","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2018.11.013_bib102","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.11.013_bib103","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1016\/j.bmcl.2016.07.010","article-title":"Design, synthesis and antimalarial evaluation of novel thiazole derivatives","volume":"26","author":"Bueno","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.013_bib104","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejmech.2014.06.022","article-title":"Synthesis and antiparasitic activity of new bis-arylimidamides: DB766 analogs modified in the terminal groups","volume":"83","author":"Liu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bmcl.2013.12.022","article-title":"Synthesis and biological evaluation of 2-aminothiazole derivatives as antimycobacterial and antiplasmodial agents","volume":"24","author":"Mjambili","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.013_bib106","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2015.02.038","article-title":"New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents","volume":"94","author":"Bekhit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib107","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejmech.2017.11.053","article-title":"Synthesis and biological evaluation of some novel diastereoselective benzothiazole \u03b2-lactam conjugates","volume":"143","author":"Alborz","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib108","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.11.013_bib109","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1461-5347(98)00097-2","article-title":"Physical chemical properties of oral drug candidates in the discovery and exploratory development settings","volume":"1","author":"Curatolo","year":"1998","journal-title":"Pharmaceut. Sci. Technol. Today"},{"key":"10.1016\/j.ejmech.2018.11.013_bib110","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1021\/mp300537k","article-title":"In silico physicochemical parameter predictions","volume":"10","author":"Wenlock","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2018.11.013_bib111","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S1359-6446(05)03584-1","article-title":"Computing chemistry on the web","volume":"10","author":"Tetko","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2018.11.013_bib112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and developmental settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2018.11.013_bib113","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2018.11.013_bib114","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/fmb.14.125","article-title":"The future for early-stage tuberculosis drug discovery","volume":"10","author":"Zuniga","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ejmech.2018.11.013_bib115","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.bmc.2014.12.031","article-title":"Perspective: challenges and opportunities in TB drug discovery from phenotypic screening","volume":"23","author":"Manjunatha","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib116","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Waring","year":"2010","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.11.013_bib117","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.26208","article-title":"High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury","volume":"58","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2018.11.013_bib118","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/jm301514n","article-title":"Contributions of molecular properties to drug promiscuity","volume":"56","author":"Tarcsay","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib119","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.bmcl.2015.04.081","article-title":"Synthesis and antimicrobial evaluation of 5-aryl-1,2,4-triazole-3- thione derivatives containing a rhodanine moiety","volume":"25","author":"Li","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib120","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3390\/molecules23051023","article-title":"Synthesis and antibacterial activity of new thiazolidine-2,4-dione-based chlorophenylthiosemicarbazone hybrids","volume":"23","author":"Trotsko","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.11.013_bib121","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1039\/C5OB01638J","article-title":"Synthesis and antimicrobial activity of Binaphthyl-based, functionalized oxazole and thiazole peptidomimetics","volume":"13","author":"Wales","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib122","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00044-018-2136-6","article-title":"Synthesis, molecular docking, ctDNA interaction, DFT calculation and evaluation of antiproliferative and anti-Toxoplasma gondii activities of 2,4-diaminotriazine-thiazole derivatives","volume":"27","author":"\u0141\u0105czkowski","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.11.013_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2014.12.031","article-title":"Thiazole: a promising heterocycle for the development of potent CNS active agents","volume":"92","author":"Mishra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib124","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejps.2013.11.001","article-title":"In\u00a0vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives","volume":"52","author":"Makama","year":"2014","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2018.11.013_bib125","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1016\/j.bmcl.2016.07.010","article-title":"Design, synthesis and antimalarial evaluation of novel thiazole derivatives Jos\u00e9 Mar\u00eda Bueno","volume":"26","author":"Bueno","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib126","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.bmc.2016.01.059","article-title":"Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors","volume":"24","author":"Samala","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib127","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejmech.2013.08.054","article-title":"2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in\u00a0vitro antimycobacterial studies","volume":"69","author":"Makam","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib128","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/jm011025r","article-title":"Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs","volume":"45","author":"Hutchinson","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib129","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ejmech.2017.12.040","article-title":"Synthesis, anticancer activity and mechanism of action of new thiazole derivatives","volume":"144","author":"Santana","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-018-0439-9","article-title":"A\u00a0facile synthesis, and antimicrobial and anticancer activities of some pyridines, thioamides, thiazole, urea, quinazoline, \u03b2-naphthyl carbamate, and pyrano[2,3-d] thiazole derivatives","volume":"12","author":"Zaki","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2018.11.013_bib131","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1021\/jm500724x","article-title":"Modification and biological evaluation of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion","volume":"57","author":"Zheng","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib132","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4155\/fmc-2017-0182","article-title":"Oxazole and thiazole analogs of sulindac for cancer prevention","volume":"10","author":"Mathew","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib133","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1016\/j.ejmech.2010.07.029","article-title":"Chiral 6-hydroxymethyl-1H,3Hpyrrolo[1,2-c]thiazoles: novel antitumor DNA monoalkylating agents","volume":"45","author":"Soares","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib134","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejmech.2012.11.036","article-title":"Chiral 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles with antibreast cancer properties","volume":"60","author":"Soares","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib135","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3390\/molecules23061318","article-title":"Design, synthesis, and evaluation of a new series of thiazole-based anticancer agents as potent Akt inhibitors","volume":"23","author":"Alt\u0131ntop","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.11.013_bib136","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1021\/jm060727j","volume":"49","author":"Das","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib137","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1590\/S0100-40422003000300014","article-title":"Drogas anti-VIH: passado, presente e perspectivas futuras","volume":"26","author":"De Souza","year":"2003","journal-title":"Quim. Nova"},{"key":"10.1016\/j.ejmech.2018.11.013_bib138","first-page":"165","article-title":"Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole","volume":"11","author":"Pasqualotto","year":"2010","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2018.11.013_bib139","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: a new thiazolide antiparasitic agent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.11.013_bib140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0090-9556(25)08319-9","article-title":"NIZATIDINE, an H2-BLOCKER its metabolism and disposition in man","volume":"14","author":"Knadler","year":"1986","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2018.11.013_bib141","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.compbiolchem.2018.05.008","article-title":"Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone","volume":"75","author":"Khan","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib142","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lfs.2018.04.024","article-title":"4-Fluorobenzaldehyde limonene-based thiosemicarbazone induces apoptosis in PC-3 human prostate cancer cells","volume":"203","author":"Rodrigues","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2018.11.013_bib143","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2018.02.009","article-title":"Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: cytotoxicity and thioredoxin reductase targeting","volume":"148","author":"Rodr\u00edguez-Fanjul","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib144","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2221-1691(12)60072-0","article-title":"In\u00a0vivo anticancer activity of vanillin semicarbazone","volume":"2","author":"Ali","year":"2012","journal-title":"Asian Pac J Trop Biomed"},{"key":"10.1016\/j.ejmech.2018.11.013_bib145","doi-asserted-by":"crossref","first-page":"36868","DOI":"10.1038\/srep36868","article-title":"Downregulation of oncogenic RAS and c-Myc expression in MOLT-4 leukaemia cells by a salicylaldehyde semicarbazone copper(II) complex","volume":"6","author":"Goh","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.11.013_bib146","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejmech.2014.10.022","article-title":"Design, synthesis and biological evaluation of novel thieno[3,2-d] pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents","volume":"87","author":"Liu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib147","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jinorgbio.2017.09.012","article-title":"Synthesis, crystal structure and antiproliferative mechanisms of 2-acetylpyridine-thiosemicarbazones Ga(III) with a greater selectivity against tumor cells","volume":"177","author":"Qi","year":"2017","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib148","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejmech.2018.05.016","article-title":"Synthesis, antiproliferative activity and mechanism of gallium(III)-thiosemicarbazone complexes as potential anti-breast cancer agents","volume":"154","author":"Qi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.013_bib149","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ardp.201300188","article-title":"Synthesis and biological evaluation of novel 4-(2-fluorophenoxy)-2-(1H-tetrazol-1-yl)pyridines bearing semicarbazone moieties as potent antitumor agents","volume":"346","author":"Qin","year":"2013","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2018.11.013_bib150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ardp.201300087","article-title":"Synthesis and biological evaluation of 4-Phenoxy-6,7-disubstituted quinolines possessing semicarbazone scaffolds as selective c-met inhibitors","volume":"346","author":"Qi","year":"2013","journal-title":"Arch. Pharm. Chem. Life Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830967X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830967X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:48:56Z","timestamp":1759326536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341830967X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":150,"alternative-id":["S022352341830967X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.013","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}